Zhejiang Ruixin Pharmaceutical Co., Ltd.
-
Founded in:
2002-01-08 -
Country:
China -
Address:
Development Road, Tianning Industrial Zone, Liandu District, Lishui City, Zhejiang Province -
Tax NO.:
91330000735259021T -
Registered Funds:
50 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Riboflavin and riboflavin derivatives |
Converted into FMN and FAD, which are important coenzymes for tissue respiration, and can activate vitamin B6 to convert tryptophan into niacin, which may be related to maintaining the integrity of red blood cells
More
Converted into FMN and FAD, which are important coenzymes for tissue respiration, and can activate vitamin B6 to convert tryptophan into niacin, which may be related to maintaining the integrity of red blood cells |
0 | ||
| Vitamin B12 |
Specific pharmacological effects are not mentioned separately and are included in the riboflavin-related effects
More
Specific pharmacological effects are not mentioned separately and are included in the riboflavin-related effects |
68-19-9 | 16 | |
| VE |
Specific pharmacological effects are not mentioned separately and are included in the riboflavin-related effects
More
Specific pharmacological effects are not mentioned separately and are included in the riboflavin-related effects |
4345-03-3 | 0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 2-Oxidized-1-pyrrolidinyl acetamide |
It is a similar substance of aminobutyric acid, which can activate, protect and repair brain cells, improve brain hypoxia, activate brain cells, increase the ATP/ADP ratio in the brain, promote the absorption of amino acids and phospholipids, protein synthesis, glucose utilization and energy storage, promote brain metabolism, increase cerebral blood flow. It can accelerate the speed of information transmission between the cerebral hemispheres through the corpus callosum, and improve the ability of learning, memory and thinking activities.
More
It is a similar substance of aminobutyric acid, which can activate, protect and repair brain cells, improve brain hypoxia, activate brain cells, increase the ATP/ADP ratio in the brain, promote the absorption of amino acids and phospholipids, protein synthesis, glucose utilization and energy storage, promote brain metabolism, increase cerebral blood flow. It can accelerate the speed of information transmission between the cerebral hemispheres through the corpus callosum, and improve the ability of learning, memory and thinking activities. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Nicorandil |
Anti-angina drug. This product belongs to the nitrate compound, which has the effect of preventing the free calcium ions in cells, increasing the permeability of cell membranes to potassium ions, dilating coronary blood vessels, continuously increasing coronary blood flow, and inhibiting coronary artery spasm. When dilating coronary blood vessels, it does not affect blood pressure, heart rate, myocardial contractility, and myocardial oxygen consumption. This product also has the effect of inhibiting platelet aggregation and preventing thrombosis.
More
Anti-angina drug. This product belongs to the nitrate compound, which has the effect of preventing the free calcium ions in cells, increasing the permeability of cell membranes to potassium ions, dilating coronary blood vessels, continuously increasing coronary blood flow, and inhibiting coronary artery spasm. When dilating coronary blood vessels, it does not affect blood pressure, heart rate, myocardial contractility, and myocardial oxygen consumption. This product also has the effect of inhibiting platelet aggregation and preventing thrombosis. |
65141-46-0 | 33 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cimetidine |
This product is a histamine H2-receptor antagonist, which blocks the effect of histamine on the H2-receptor of parietal cells through a competitive inhibition mechanism. It inhibits basal gastric acid secretion during the day and at night, and also inhibits gastric acid secretion caused by food, histamine, pentagastrin, caffeine and insulin. When the blood drug concentration exceeds 0.5mg/L, it can usually achieve more than 80% inhibition of gastric acid secretion. It has a strong inhibitory effect on irritant gastric acid secretion and does not affect the basal level of intrinsic factor. It has no effect on gastric emptying rate and lower esophageal sphincter pressure.
More
This product is a histamine H2-receptor antagonist, which blocks the effect of histamine on the H2-receptor of parietal cells through a competitive inhibition mechanism. It inhibits basal gastric acid secretion during the day and at night, and also inhibits gastric acid secretion caused by food, histamine, pentagastrin, caffeine and insulin. When the blood drug concentration exceeds 0.5mg/L, it can usually achieve more than 80% inhibition of gastric acid secretion. It has a strong inhibitory effect on irritant gastric acid secretion and does not affect the basal level of intrinsic factor. It has no effect on gastric emptying rate and lower esophageal sphincter pressure. |
51481-61-9 | 35 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Benproperine phosphate |
This product is a non-narcotic antitussive drug that mainly blocks the afferent sensory nerve impulses of the lung and pleural receptors, and also directly inhibits the antitussive center. It also has a papaverine-like smooth muscle spasmolytic effect.
More
This product is a non-narcotic antitussive drug that mainly blocks the afferent sensory nerve impulses of the lung and pleural receptors, and also directly inhibits the antitussive center. It also has a papaverine-like smooth muscle spasmolytic effect. |
26.4mg | 19428-14-9 | 19 |